Logo

Get Healthy!

Results for search "Drug Approvals".

Health News Results - 7

THURSDAY, Aug. 15, 2019 (HealthDay News) -- A new drug has been approved as part of a powerful, three-pronged treatment regimen for the most deadly strain of tuberculosis, the U.S. Food and Drug Administration announced Wednesday.

Pretomanid tablets were approved to be used with bedaquiline and linezolid in adults with extensive multidrug-resistant tuberculosis (XDR-TB) of the lungs....

MONDAY, April 1, 2019 (HealthDay News) -- The U.S. Food and Drug Administration has approved another new multiple sclerosis drug -- the second in one week.

Mavenclad (cladribine) pills can be used to treat relapsing forms of MS in adults, including relapsing-remitting disease and active secondary progressive disease. The drug is not recommended for MS patients with a course of the dis...

WEDNESDAY, March 13, 2019 (HealthDay News) -- The U.S. Food and Drug Administration on Tuesday approved a new generic version of the high blood pressure/heart failure drug valsartan, saying the move might help ease the current medication shortage.

The agency said it prioritized review of the drug from Alkem Laboratories Ltd. after multiple recalls of other generic valsartan products d...

TUESDAY, Feb. 5, 2019 (HealthDay News) -- Easing chronic pain is the main reason Americans use medical marijuana, a new study finds.

"We wanted to understand the reasons why people are using cannabis medically, and whether those reasons for use are evidence-based," said lead author Kevin Boehnke. He's an investigator at University of Michigan's Chronic Pain and Fatigue Research Center...

THURSDAY, Jan. 31, 2019 (HealthDay News) -- The first generic version of the widely used Advair Diskus inhaler for asthma and chronic obstructive pulmonary disease (COPD) has won U.S. Food and Drug Administration approval.

This approval "is part of our longstanding commitment to advance access to lower cost, high-quality generic alternatives," said Dr. Janet Woodcock, director of the ...

WEDNESDAY, Sept. 12, 2018 (HealthDay News) -- Researchers say the first drug for children with multiple sclerosis vastly outperformed another common MS medication in a new clinical trial.

Fingolimod (Gilenya) reduced relapse rates by 82 percent in patients aged 10 to 17 compared with interferon beta-1a, a drug commonly used to slow the progression of the degenerative nerve disease.

THURSDAY, Feb. 15, 2018 (HealthDay News) -- The U.S. National Institutes of Health spent more than $100 billion on research that led to 210 new medicines gaining U.S. Food and Drug Administration approval over six years, a new study shows.

Nearly $64 billion of that spending was for the development of 84 first-in-class drugs that use new biological mechanisms or targets.

The...